1..
ORCL·Technology·AI
Oracle Forecast +2.8% Rally: Can AI Cash Flows Justify $400?
Can an eye‑popping Oracle Forecast built on AI data centers and OpenAI demand really power the stock toward a $400…
Stocks
1..
ORCL·Technology·AI
1..
CRWD·Technology·Cloud Computing
CrowdStrike Strategy +5.2% Rally: AI Security Boom Ahead
Is the latest CrowdStrike Strategy and its AI security push enough to justify the stock’s powerful +5.2% rally? Maik Kemper…
1..
NOC·Industrials·Defense
Northrop Grumman Earnings -5.1% Plunge After Strong Quarter
Can Northrop Grumman’s booming bomber and missile programs offset a sharp share-price drop after its latest earnings report? Maik Kemper…
1..
BB·Technology·Meme Stocks
BlackBerry Nvidia Partnership Sparks New AI Boom Warning
Can the expanded BlackBerry Nvidia Partnership turn QNX into a quiet AI winner while fresh security concerns cloud the upside?…
1..
GE·Industrials
GE Aerospace Earnings Record: 87% Order Surge Shocks Investors
Can blockbuster GE Aerospace Earnings and a record order book outweigh a sharp pre-market drop in the stock? Maik Kemper…
1..
UNH·Healthcare
UnitedHealth Earnings Q1 Beat as AI Spend Surges
Are stronger UnitedHealth Earnings and a billion‑dollar AI push enough to turn last year’s turmoil into a durable 2026 comeback?…
1..
AAPL·Technology·Magnificent 7
Apple CEO Transition Warning: Can Hardware Lead an AI Boom?
Will the Apple CEO Transition to John Ternus unlock a new hardware-led AI chapter or expose how far the tech…
1..
PLTR·Technology·AI
Palantir Presidential endorsement: valuation Warning for PLTR
Can the Palantir Presidential endorsement really move the needle for PLTR, or will stretched AI valuations keep a lid on…
1..
LLY·Healthcare·Pharma
Eli Lilly Acquisition Boom: Multi‑Billion Cancer and Obesity Bet
Can the latest Eli Lilly Acquisition in next‑gen cancer therapy really justify its sky‑high valuation beyond the obesity drug boom?…
1..
MSFT·Technology·AI
Microsoft AI Strategy Boom: $37.5B Capex Shock for Investors
Is the aggressive Microsoft AI Strategy a value-creating moonshot or an overbuilt capex gamble that could spook investors for years?…